Insider · CIK 0001883230
Jonathan Barrett MacKenzie
Files at MED (MEDIFAST INC). First filing -, latest -.
In brief
Jonathan Barrett MacKenzie files SEC Form 4 as officer at MED (MEDIFAST INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jonathan Barrett MacKenzie has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | MED MEDIFAST INC | FTax withholding Common Stock | -198 | $9.62 | $1,905 | 10,940 | Mar 27, 2026 |
| Mar 17, 2026 | MED MEDIFAST INC | FTax withholding Common Stock | -70 | $10.05 | $704 | 10,870 | Mar 27, 2026 |
| Mar 25, 2026 | MED MEDIFAST INC | FTax withholding Common Stock | -862 | $9.59 | $8,267 | 10,008 | Mar 27, 2026 |
| Mar 25, 2026 | MED MEDIFAST INC | AGrant or award Common Stock | +10,830 | $0.00 | $0 | 20,838 | Mar 27, 2026 |
Questions about Jonathan Barrett MacKenzie
Answered from the filings on this page, as of the latest one.
Is Jonathan Barrett MacKenzie buying or selling?
Jonathan Barrett MacKenzie has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jonathan Barrett MacKenzie's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jonathan Barrett MacKenzie has 0.
Where does Jonathan Barrett MacKenzie file Form 4?
Jonathan Barrett MacKenzie has filed Form 4 at MED (MEDIFAST INC) as VP, Finance & CAO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.